Drugs
-
Νέα ΔΟΘ
TIF Participates in EMA’s Annual Training Day 2020
TIF has participated in the Annual Training Day of the European Medicines Agency (EMA), held on 23 October 2020. TIF participants, Ms Lily Cannon (TIF Operations Manager) and Ms Eleni…
Read More » -
Νέα
FDA Approves New Formulation for Ferriprox (Deferiprone) Twice-a-Day Tablets
Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., today announced that the U.S. Food and Drug Administration (FDA) has approved Ferriprox® (deferiprone) twice-a-day tablets for the treatment…
Read More » -
TIF Publications
Developing Vaccinations & Therapeutic Drugs for COVID-19 (2020)
A list of studies/clinical trials for developing treatments and vaccines for the COVID-19 pandemic. This list is by no means exhaustive, since research in this field is ongoing.
Read More »